dos Santos Crisóstomo RS, Costa DS, de Luz Belo Martins C, Fernandes TI, Armada-da-Silva PA, et al.
Archives of physical medicine and rehabilitation. Date of publication 2015 Feb 1;volume 96(2):283-91.
1. Arch Phys Med Rehabil. 2015 Feb;96(2):283-91. doi: 10.1016/j.apmr.2014.09.020.
Epub 2014 Oct 13.
Influence of manual lymphatic drainage on health-related quality of life and
symptoms of chronic venous insufficiency: a randomized controlled trial.
dos Santos Crisóstomo RS(1), Costa DS(2), de Luz Belo Martins C(3), Fernandes
TI(3), Armada-da-Silva PA(4).
Author information:
(1)Laboratório de Biomecânica e Morfologia Funcional, Faculdade de Motricidade
Humana, Universidade de Lisboa, Estrada da Costa, Lisboa, Portugal; Centro
Interdisciplinar para o Estudo da Performance Humana, Faculdade de Motricidade
Humana, Universidade de Lisboa, Estrada da Costa, Lisboa, Portugal; Instituto
Politécnico de Castelo Branco, Escola Superior de Saúde Dr. Lopes Dias, Castelo
Branco, Portugal. Electronic address: crisostomo.rute@ipcb.pt.
(2)Instituto Politécnico de Castelo Branco, Escola Superior de Saúde Dr. Lopes
Dias, Castelo Branco, Portugal; Clinica Médico-Cirúrgica das Violetas, Castelo
Branco, Portugal.
(3)Instituto Politécnico de Castelo Branco, Escola Superior de Saúde Dr. Lopes
Dias, Castelo Branco, Portugal.
(4)Laboratório de Biomecânica e Morfologia Funcional, Faculdade de Motricidade
Humana, Universidade de Lisboa, Estrada da Costa, Lisboa, Portugal; Centro
Interdisciplinar para o Estudo da Performance Humana, Faculdade de Motricidade
Humana, Universidade de Lisboa, Estrada da Costa, Lisboa, Portugal.
OBJECTIVE: To evaluate the efficacy of manual lymphatic drainage (MLD) in
improving health-related quality of life (HRQOL), symptomatology, and physical
status in patients with chronic venous insufficiency (CVI).
DESIGN: Single-blind randomized controlled trial.
SETTING: Health community attendant service.
PARTICIPANTS: Subjects with CVI (N=41) were randomly assigned to an experimental
group (n=20; mean age, 54.6±11.3y) or control group (n=21; mean age, 46.8±11.1y).
INTERVENTIONS: The experimental group completed 10 lower extremity MLD sessions
over 4 weeks and 1 educational session. The control group only attended the
educational session. Outcome measures were taken at baseline (t0), at the end of
4 weeks (t1), and after 2 months for follow-up (t2).
MAIN OUTCOME MEASURES: HRQOL was assessed with the Chronic Venous Insufficiency
Quality of Life Questionnaire-20, symptoms (fatigue, heaviness) were assessed
with a visual analog scale, severity of the disease was assessed with the Venous
Clinical Severity Score (VCSS) (total score, score for each item), leg volumetry
was assessed with perimeters, and plantar/dorsiflexion strength and ankle range
of motion (ROM) were assessed with dynamometry.
RESULTS: A significant interaction group×time effect was found for pain on HRQOL
(F2,78=3.507; P=.035; partial η2=.087), clinical severity (F2,78=5.231; P=.007;
partial η2=.118), especially for venous edema (assessed with the VCSS), fatigue
(F1.67,65.21=4.690; P=.012; partial η2=.107), and heaviness (F1.57,61.32=9.702;
P=.001; partial η2=.199), with the experimental group improving from t0 to t1 and
t0 to t2 in all of these outcomes. No effect of MLD treatment could be found for
ankle muscle strength, ankle ROM, and leg volume.
CONCLUSIONS: Short-term MLD treatment ameliorates CVI severity and related edema,
symptoms, and pain HRQOL in patients with CVI.
Copyright © 2015 American Congress of Rehabilitation Medicine. Published by
Elsevier Inc. All rights reserved.
DOI: 10.1016/j.apmr.2014.09.020
PMID: 25308883 [Indexed for MEDLINE]
